Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging

European Journal of Nuclear Medicine

Volumn 23, Issue 5, 1996, Pages 524-529

  Ricci, Monica ^a,b   Pantano, Patrizia ^a   Pierallini, Alberto ^a   Di Stefano, Domenica ^a   Santoro, Antonio ^a   Bozzao, Luigi ^a   Lenzi, Gian Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipartimento Scienze Neurologiche   (Italy)

Author keywords

Glioblastoma; Magnetic resonance imaging; Neuro oncology; Thallium 201 single photon emission tomography; Tumoral necrosis

Indexed keywords

RADIOPHARMACEUTICAL AGENT; THALLIUM CHLORIDE TL 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON EMISSION TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR NECROSIS; TUMOR SCINTISCANNING; TUMOR VOLUME;

EID: 0029971222     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00833386     Document Type: Article

References (40)

1. Lebowitz E, Greene MW, Fairchild R. Thallium-201 for medical use. J Nucl Med 1974; 28: 47-52.
2. Ancri D, Bassett JY. Diagnosis of cerebral lesion by thallium-201. Radiology 1978; 128: 417-422.
3. Ancri D, Basset JY. Diagnosis of cerebral metastases by thallium-201. Br J Radiol 1980; 53: 443-453.
4. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thalium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
5. Kaplan WD, Takronan T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987; 28: 47-52.
6. Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, Ueda T, Wakisaka S. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 1993; 34: 2091-2094.
7. Borggreve F, Dierckx RA, Crols R, Mathijs R, Appel B, Vandevivere J, Marien P, Martin JJ, DeDeyn PP. Repeat thallium-201 SPECT in cerebral lymphoma. Funct Neurol 1993; 8: 95-101.
8. +)ATPase activity with growth of normal and transformed cells. Exp Cell Res 1974; 87: 233-240.
9. +-activated adenosine triphosphatase activity in transformed fibroblasts. Cancer Res 1974; 34: 1862-1865.
10. 201Tl uptake in tumours. Eur J Nucl Med 1989; 15: 376-379.
11. Mountz JM, Stafford-Schuck K, McKeever PE, Taren J, Beierwaltes WH. Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg 1988; 68: 705-709.
12. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, Tomiyoshi K, Hirano T, Inoue T, Endo K. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
13. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, De Deyn PP. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21: 621-633.
14. Buckard R, Kaiser KP, Wieler H, Klawki P, Linkamp A, Mittelbach L, Goller T. Contribution of thallium-201 to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15: 265-273.
15. Hoh CK, Khanna S, Harris GC, Chen TT, Black KL, Becker DP, Maddahi J, Mazziotta JC, Marciano DM, Hawkins RA. Evaluation of brain tumor recurrence with thallium-201 SPECT studies: correlation with FDG-PET and histological results [abstract]. J Nucl Med 1992; 33: 867.
16. Carvalho PA, Schwartz RB, Alexander E III, Garada BM, Zimmerman RE, Loeffler JS, Leonard Holman B. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992; 77: 565-570.
17. Kosuda S, Aoki S, Suzuki K, Nakamura O, Shidara N. Reevaluation of quantitative thallium-201 SPECT for brain tumor [abstract]. J Nucl Med 1992; 33: 844.
18. 99mTc-HMPAO. AJNR 1992; 12: 1187-1192.
19. Ricci M, Pantano P, Maleci A, Bastianello S, Salvati M, Bozzao L, Cantore G, Lenzi GL. Differentiation of radiation necrosis from recurrent gliomas: role of morphological (CT and MR) and functional (SPECT with thallium-201) assessment. Ital J Neurol Sci 1993; 6: 504-505.
20. Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, Hawkins RA, Becker DP. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31: 965-969.
21. Yoshii Y, Satou M, Yamamoto T, Hyodo A, Nose T, Ishikawa H, Hatakeyama R. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 1993; 20: 39-45.
22. Carlin RD, Jan K. Mechanism of thallium extraction in pump perfused canine hearts. J Nucl Med 1985; 26: 165-169.
23. Atkins HL, Budinger TF, Labowitz E, et al. Thallium-201 for medical use. Part 3: human distribution and physical imaging properties. J Nucl Med 1977; 18: 133-140.
24. Sorenson JA, Phelps ME. Physics in nuclear medicine, 2nd edn. Orlando, NY, Greene & Stratton, 1987: 406-408.
25. Kleihues P, Burger PC, Scheilhauer BW. The new classification of brain tumors. Brain Pathol 1993; 3: 255-268.
26. Pierallini A, Bonamini M, Osti MF, Pantano P, Palmeggiani F, Santoro A, Maurizi Enrici R, Bozzao L. Supratentorial glioblastoma: relationship between neuroradiological findings and survival after surgery and radiotherapy. Neuroradiology (in press)
27. Mountz JM, Raymond PA, McKeever PE, Modell JG, Hood TW, Barthel LK, Stafford-Schuck KA. Specific localization of thallium-201 in human high-grade astrocytoma by microautoradiography. Cancer Res 1989; 49: 4052-4056.
28. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
29. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis is a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 1983; 52: 550-554.
30. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985; 56: 1106-1111.
31. Piszczor M, Thornton G, Bia FJ. The evaluation of contrast-enhancing brain lesion: pitfalls in current practice (clinical conference). Yale J Biol Med 1985; 58: 19-27.
32. Heimes AB, Zimmerman RD, Morgello S, Weingarten K, Becker RD, Jennis R, Deck MDF. MR imaging of brain abscesses. AJNR 1989; 10: 279-291.
33. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993; 33: 18-27.
34. Tonami H, Matsuda H, Ooba H, et al. Thallium-201 accumulation in cerebral candidiasis. Clin Nucl Med 1990; 15: 397-400.
35. Krishna L, Slizofski WJ, Katsetos CD, Nair S, Dadparvar S, Brown SJ, Chevres A, Roman R. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992; 33: 2017-2019.
36. 201Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987; 12: 567-572.
37. Ruiz A, Ganz WI, Donovan Post J, Camp A, Landy H, Mallin W, Sfakianakis GN. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR 1994; 15: 1885-1894.
38. O'Tuama LA, Treves ST, Larar JN, Packard AB, Kwan AJ, Barnes PD, Scott RM, Black PMacL, Madsen JR, Goumnerova LC, Sallan SE, Tarbell NJ. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
39. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scan of patients with supratentorial malignant gliomas. Neurology 1988; 38: 1371-1374.
40. Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989; 500: 30-36.